Author
Universitätsklinikum Tübingen
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
3 papers
Recent·Most cited
Melanie Sauer, Xavier Segarra-Visent, Leon Breuer…·Réka Ágnes Haraszti
This study shows that cryopreservation of siRNA-treated cells maintains silencing efficacy, with optimal siRNA exposure duration and temperature.
Anastasia Kremer, Tatyana Ryaykenen, Xavier Segarra-Visent…·Réka Ágnes Haraszti
This study examines how chemical modifications affect the duration of RNAi-based therapies in rapidly dividing cells, finding that specific modifications can extend silencing duration significantly.
Xavier Segarra-Visent, Tatyana Ryaykenen, Anastasia Kremer…·Réka Ágnes Haraszti
This study identifies a miR-374b mimic that selectively inhibits GVHD while enhancing GvL, demonstrating the potential of chemically modified miRNA therapies to improve T-cell-based cancer treatments.